Long Term Prognosis of Neuroinvasive West Nile Infection

Overview

About this study

The purpose of this study is to assess short and long term outcomes and factors related to poor prognosis in patients with neuroinvasive West Nile disease

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with diagnosis of neuroinvasive West Nile infection will be identified from Saint Mary’s Hospital, Rochester, Minnesota data base.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Alejandro Rabinstein, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20303081

Mayo Clinic Footer